Table 2.

Grade 2 or higher adverse events associated with ibrutinib and venetoclax therapies

Adverse eventGrade 2Grade 3Grade 4Grade 5
Alanine aminotransferase increase    
Anemia    
Anorexia    
Arthralgia   
Atrial fibrillation   
Bruising    
Diarrhea 11   
Fatigue   
Gastroesophageal reflux disease 12    
Headache    
Hematoma    
Hematuria    
Hyperphosphatemia    
Hypertension   
Hyponatremia    
Intracranial hemorrhage    
Lung infection    
Malaise    
Mucositis   
Myalgia    
Nausea    
Neutropenia 13  
Platelet decrease    
Skin rash    
Soft tissue infection   
Tumor lysis syndrome    
Upper respiratory infection    
Urinary tract infection    
Ventricular arrhythmia  
Adverse eventGrade 2Grade 3Grade 4Grade 5
Alanine aminotransferase increase    
Anemia    
Anorexia    
Arthralgia   
Atrial fibrillation   
Bruising    
Diarrhea 11   
Fatigue   
Gastroesophageal reflux disease 12    
Headache    
Hematoma    
Hematuria    
Hyperphosphatemia    
Hypertension   
Hyponatremia    
Intracranial hemorrhage    
Lung infection    
Malaise    
Mucositis   
Myalgia    
Nausea    
Neutropenia 13  
Platelet decrease    
Skin rash    
Soft tissue infection   
Tumor lysis syndrome    
Upper respiratory infection    
Urinary tract infection    
Ventricular arrhythmia  
Close Modal

or Create an Account

Close Modal
Close Modal